Global NGS Based Diagnostics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

SKU ID : QYR-21797964 | Publishing Date : 03-Oct-2022 | No. of pages : 114

Detailed TOC of Global NGS Based Diagnostics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global NGS Based Diagnostics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 DNA Sequencing
        1.2.3 RNA Sequencing
        1.2.4 Whole Genome Sequencing
        1.2.5 Whole Exome Sequencing
        1.2.6 Other
    1.3 Market by Application
        1.3.1 Global NGS Based Diagnostics Market Growth Rate by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Academics/Research Institutions
    1.4 Study Objectives
    1.5 Years Considered
2 Market Perspective
    2.1 Global NGS Based Diagnostics Market Size (2017-2028)
    2.2 NGS Based Diagnostics Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
    2.3 Global NGS Based Diagnostics Market Size by Region (2017-2022)
    2.4 Global NGS Based Diagnostics Market Size Forecast by Region (2023-2028)
    2.5 Global Top NGS Based Diagnostics Countries Ranking by Market Size
3 NGS Based Diagnostics Competitive by Company
    3.1 Global NGS Based Diagnostics Revenue by Players
        3.1.1 Global NGS Based Diagnostics Revenue by Players (2017-2022)
        3.1.2 Global NGS Based Diagnostics Market Share by Players (2017-2022)
    3.2 Global NGS Based Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Company Covered: Ranking by NGS Based Diagnostics Revenue
    3.4 Global NGS Based Diagnostics Market Concentration Ratio
        3.4.1 Global NGS Based Diagnostics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by NGS Based Diagnostics Revenue in 2021
    3.5 Global NGS Based Diagnostics Key Players Head office and Area Served
    3.6 Key Players NGS Based Diagnostics Product Solution and Service
    3.7 Date of Enter into NGS Based Diagnostics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Global NGS Based Diagnostics Breakdown Data by Type
    4.1 Global NGS Based Diagnostics Historic Revenue by Type (2017-2022)
    4.2 Global NGS Based Diagnostics Forecasted Revenue by Type (2023-2028)
5 Global NGS Based Diagnostics Breakdown Data by Application
    5.1 Global NGS Based Diagnostics Historic Market Size by Application (2017-2022)
    5.2 Global NGS Based Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America NGS Based Diagnostics Revenue by Company (2020-2022)
    6.2 North America NGS Based Diagnostics Revenue by Type (2017-2028)
    6.3 North America NGS Based Diagnostics Revenue by Application (2017-2028)
    6.4 North America NGS Based Diagnostics Revenue by Country (2017-2028)
        6.4.1 U.S.
        6.4.2 Canada
7 Europe
    7.1 Europe NGS Based Diagnostics Revenue by Company (2020-2022)
    7.2 Europe NGS Based Diagnostics Revenue by Type (2017-2028)
    7.3 Europe NGS Based Diagnostics Revenue by Application (2017-2028)
    7.4 Europe NGS Based Diagnostics Revenue by Country (2017-2028)
        7.4.1 Germany
        7.4.2 France
        7.4.3 U.K.
        7.4.4 Italy
        7.4.5 Russia
8 Asia Pacific
    8.1 Asia Pacific NGS Based Diagnostics Revenue by Company (2020-2022)
    8.2 Asia Pacific NGS Based Diagnostics Revenue by Type (2017-2028)
    8.3 Asia Pacific NGS Based Diagnostics Revenue by Application (2017-2028)
    8.4 Asia Pacific NGS Based Diagnostics Revenue by Region (2017-2028)
        8.4.1 China
        8.4.2 Japan
        8.4.3 South Korea
        8.4.4 India
        8.4.5 Australia
        8.4.6 Taiwan
        8.4.7 Indonesia
        8.4.8 Thailand
        8.4.9 Malaysia
        8.4.10 Philippines
        8.4.11 Vietnam
9 Latin America
    9.1 Latin America NGS Based Diagnostics Revenue by Company (2020-2022)
    9.2 Latin America NGS Based Diagnostics Revenue by Type (2017-2028)
    9.3 Latin America NGS Based Diagnostics Revenue by Application (2017-2028)
    9.4 Latin America NGS Based Diagnostics Revenue by Country (2017-2028)
        9.4.1 Mexico
        9.4.2 Brazil
        9.4.3 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa NGS Based Diagnostics Revenue by Company (2020-2022)
    10.2 Middle East and Africa NGS Based Diagnostics Revenue by Type (2017-2028)
    10.3 Middle East and Africa NGS Based Diagnostics Revenue by Application (2017-2028)
    10.4 Middle East and Africa NGS Based Diagnostics Revenue by Country (2017-2028)
        10.4.1 Turkey
        10.4.2 Saudi Arabia
        10.4.3 UAE
11 Company Profiles
    11.1 Janssen
        11.1.1 Janssen Company Details
        11.1.2 Janssen Business Overview
        11.1.3 Janssen NGS Based Diagnostics Products and Services
        11.1.4 Janssen NGS Based Diagnostics Revenue in NGS Based Diagnostics Business (2017-2022)
        11.1.5 Janssen NGS Based Diagnostics SWOT Analysis
        11.1.6 Janssen Recent Developments
    11.2 Roche
        11.2.1 Roche Company Details
        11.2.2 Roche Business Overview
        11.2.3 Roche NGS Based Diagnostics Products and Services
        11.2.4 Roche NGS Based Diagnostics Revenue in NGS Based Diagnostics Business (2017-2022)
        11.2.5 Roche NGS Based Diagnostics SWOT Analysis
        11.2.6 Roche Recent Developments
    11.3 Qiagen
        11.3.1 Qiagen Company Details
        11.3.2 Qiagen Business Overview
        11.3.3 Qiagen NGS Based Diagnostics Products and Services
        11.3.4 Qiagen NGS Based Diagnostics Revenue in NGS Based Diagnostics Business (2017-2022)
        11.3.5 Qiagen NGS Based Diagnostics SWOT Analysis
        11.3.6 Qiagen Recent Developments
    11.4 ThermoFisher Scientific
        11.4.1 ThermoFisher Scientific Company Details
        11.4.2 ThermoFisher Scientific Business Overview
        11.4.3 ThermoFisher Scientific NGS Based Diagnostics Products and Services
        11.4.4 ThermoFisher Scientific NGS Based Diagnostics Revenue in NGS Based Diagnostics Business (2017-2022)
        11.4.5 ThermoFisher Scientific NGS Based Diagnostics SWOT Analysis
        11.4.6 ThermoFisher Scientific Recent Developments
    11.5 Oxford Gene Technology
        11.5.1 Oxford Gene Technology Company Details
        11.5.2 Oxford Gene Technology Business Overview
        11.5.3 Oxford Gene Technology NGS Based Diagnostics Products and Services
        11.5.4 Oxford Gene Technology NGS Based Diagnostics Revenue in NGS Based Diagnostics Business (2017-2022)
        11.5.5 Oxford Gene Technology NGS Based Diagnostics SWOT Analysis
        11.5.6 Oxford Gene Technology Recent Developments
    11.6 Illumina
        11.6.1 Illumina Company Details
        11.6.2 Illumina Business Overview
        11.6.3 Illumina NGS Based Diagnostics Products and Services
        11.6.4 Illumina NGS Based Diagnostics Revenue in NGS Based Diagnostics Business (2017-2022)
        11.6.5 Illumina NGS Based Diagnostics SWOT Analysis
        11.6.6 Illumina Recent Developments
    11.7 Pacific Biosciences
        11.7.1 Pacific Biosciences Company Details
        11.7.2 Pacific Biosciences Business Overview
        11.7.3 Pacific Biosciences NGS Based Diagnostics Products and Services
        11.7.4 Pacific Biosciences NGS Based Diagnostics Revenue in NGS Based Diagnostics Business (2017-2022)
        11.7.5 Pacific Biosciences NGS Based Diagnostics SWOT Analysis
        11.7.6 Pacific Biosciences Recent Developments
    11.8 Paradigm Diagnostics
        11.8.1 Paradigm Diagnostics Company Details
        11.8.2 Paradigm Diagnostics Business Overview
        11.8.3 Paradigm Diagnostics NGS Based Diagnostics Products and Services
        11.8.4 Paradigm Diagnostics NGS Based Diagnostics Revenue in NGS Based Diagnostics Business (2017-2022)
        11.8.5 Paradigm Diagnostics NGS Based Diagnostics SWOT Analysis
        11.8.6 Paradigm Diagnostics Recent Developments
    11.9 Innogene Kalbiotech
        11.9.1 Innogene Kalbiotech Company Details
        11.9.2 Innogene Kalbiotech Business Overview
        11.9.3 Innogene Kalbiotech NGS Based Diagnostics Products and Services
        11.9.4 Innogene Kalbiotech NGS Based Diagnostics Revenue in NGS Based Diagnostics Business (2017-2022)
        11.9.5 Innogene Kalbiotech NGS Based Diagnostics SWOT Analysis
        11.9.6 Innogene Kalbiotech Recent Developments
    11.10 Admera Health
        11.10.1 Admera Health Company Details
        11.10.2 Admera Health Business Overview
        11.10.3 Admera Health NGS Based Diagnostics Products and Services
        11.10.4 Admera Health NGS Based Diagnostics Revenue in NGS Based Diagnostics Business (2017-2022)
        11.10.5 Admera Health NGS Based Diagnostics SWOT Analysis
        11.10.6 Admera Health Recent Developments
    11.11 AITbiotech
        11.11.1 AITbiotech Company Details
        11.11.2 AITbiotech Business Overview
        11.11.3 AITbiotech NGS Based Diagnostics Products and Services
        11.11.4 AITbiotech NGS Based Diagnostics Revenue in NGS Based Diagnostics Business (2017-2022)
        11.11.5 AITbiotech Recent Developments
    11.12 Centogene
        11.12.1 Centogene Company Details
        11.12.2 Centogene Business Overview
        11.12.3 Centogene NGS Based Diagnostics Products and Services
        11.12.4 Centogene NGS Based Diagnostics Revenue in NGS Based Diagnostics Business (2017-2022)
        11.12.5 Centogene Recent Developments
    11.13 Phalanx Biotech Group
        11.13.1 Phalanx Biotech Group Company Details
        11.13.2 Phalanx Biotech Group Business Overview
        11.13.3 Phalanx Biotech Group NGS Based Diagnostics Products and Services
        11.13.4 Phalanx Biotech Group NGS Based Diagnostics Revenue in NGS Based Diagnostics Business (2017-2022)
        11.13.5 Phalanx Biotech Group Recent Developments
    11.14 iGenomX
        11.14.1 iGenomX Company Details
        11.14.2 iGenomX Business Overview
        11.14.3 iGenomX NGS Based Diagnostics Products and Services
        11.14.4 iGenomX NGS Based Diagnostics Revenue in NGS Based Diagnostics Business (2017-2022)
        11.14.5 iGenomX Recent Developments
12 NGS Based Diagnostics Market Dynamics
    12.1 NGS Based Diagnostics Market Trends
    12.2 NGS Based Diagnostics Market Drivers
    12.3 NGS Based Diagnostics Market Challenges
    12.4 NGS Based Diagnostics Market Restraints
13 Research Findings and Conclusion
14 Appendix
    14.1 Research Methodology
        14.1.1 Methodology/Research Approach
        14.1.2 Data Source
    14.2 Author Details

List of Figures, Tables and Charts Available in Global NGS Based Diagnostics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

List of Tables
    Table 1. Global NGS Based Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of DNA Sequencing
    Table 3. Key Players of RNA Sequencing
    Table 4. Key Players of Whole Genome Sequencing
    Table 5. Key Players of Whole Exome Sequencing
    Table 6. Key Players of Other
    Table 7. Global NGS Based Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 8. Global NGS Based Diagnostics Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
    Table 9. Global NGS Based Diagnostics Revenue by Region (2017-2022) & (US$ Million)
    Table 10. Global NGS Based Diagnostics Revenue Market Share by Region (2017-2022)
    Table 11. Global NGS Based Diagnostics Revenue by Players (2017-2022) & (US$ Million)
    Table 12. Global NGS Based Diagnostics Market Share by Players (2017-2022)
    Table 13. Global Top NGS Based Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS Based Diagnostics as of 2021)
    Table 14. Ranking of Global Top NGS Based Diagnostics Companies by Revenue (US$ Million) in 2021
    Table 15. Global 5 Largest Players Market Share by NGS Based Diagnostics Revenue (CR5 and HHI) & (2017-2022)
    Table 16. Key Players Headquarters and Area Served
    Table 17. Key Players NGS Based Diagnostics Product Solution and Service
    Table 18. Date of Key Manufacturers Enter into NGS Based Diagnostics Market
    Table 19. Mergers & Acquisitions, Expansion Plans
    Table 20. Global NGS Based Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 21. Global NGS Based Diagnostics Revenue Market Share by Type (2017-2022)
    Table 22. Global NGS Based Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 23. Global NGS Based Diagnostics Revenue Market Share by Type (2023-2028)
    Table 24. Global NGS Based Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 25. Global NGS Based Diagnostics Revenue Market Share by Application (2017-2022)
    Table 26. Global NGS Based Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 27. Global NGS Based Diagnostics Revenue Market Share by Application (2023-2028)
    Table 28. North America NGS Based Diagnostics Revenue by Company (2020-2022) & (US$ Million)
    Table 29. North America NGS Based Diagnostics Revenue by Type (2017-2022) & (US$ Million)
    Table 30. North America NGS Based Diagnostics Revenue by Type (2023-2028) & (US$ Million)
    Table 31. North America NGS Based Diagnostics Revenue by Application (2017-2022) & (US$ Million)
    Table 32. North America NGS Based Diagnostics Revenue by Application (2023-2028) & (US$ Million)
    Table 33. North America NGS Based Diagnostics Revenue by Country (2017-2022) & (US$ Million)
    Table 34. North America NGS Based Diagnostics Revenue by Country (2023-2028) & (US$ Million)
    Table 35. Europe NGS Based Diagnostics Revenue by Company (2020-2022) & (US$ Million)
    Table 36. Europe NGS Based Diagnostics Revenue by Type (2017-2022) & (US$ Million)
    Table 37. Europe NGS Based Diagnostics Revenue by Type (2023-2028) & (US$ Million)
    Table 38. Europe NGS Based Diagnostics Revenue by Application (2017-2022) & (US$ Million)
    Table 39. Europe NGS Based Diagnostics Revenue by Application (2023-2028) & (US$ Million)
    Table 40. Europe NGS Based Diagnostics Revenue by Country (2017-2022) & (US$ Million)
    Table 41. Europe NGS Based Diagnostics Revenue by Country (2023-2028) & (US$ Million)
    Table 42. Asia Pacific NGS Based Diagnostics Revenue by Company (2020-2022) & (US$ Million)
    Table 43. Asia Pacific NGS Based Diagnostics Revenue by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific NGS Based Diagnostics Revenue by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific NGS Based Diagnostics Revenue by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific NGS Based Diagnostics Revenue by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific NGS Based Diagnostics Revenue by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific NGS Based Diagnostics Revenue by Region (2023-2028) & (US$ Million)
    Table 49. Latin America NGS Based Diagnostics Revenue by Company (2020-2022) & (US$ Million)
    Table 50. Latin America NGS Based Diagnostics Revenue by Type (2017-2022) & (US$ Million)
    Table 51. Latin America NGS Based Diagnostics Revenue by Type (2023-2028) & (US$ Million)
    Table 52. Latin America NGS Based Diagnostics Revenue by Application (2017-2022) & (US$ Million)
    Table 53. Latin America NGS Based Diagnostics Revenue by Application (2023-2028) & (US$ Million)
    Table 54. Latin America NGS Based Diagnostics Revenue by Country (2017-2022) & (US$ Million)
    Table 55. Latin America NGS Based Diagnostics Revenue by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa NGS Based Diagnostics Revenue by Company (2020-2022) & (US$ Million)
    Table 57. Middle East and Africa NGS Based Diagnostics Revenue by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa NGS Based Diagnostics Revenue by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa NGS Based Diagnostics Revenue by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa NGS Based Diagnostics Revenue by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa NGS Based Diagnostics Revenue by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa NGS Based Diagnostics Revenue by Country (2023-2028) & (US$ Million)
    Table 63. Janssen Company Details
    Table 64. Janssen Business Overview
    Table 65. Janssen NGS Based Diagnostics Product and Services
    Table 66. Janssen NGS Based Diagnostics Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 67. Janssen NGS Based Diagnostics SWOT Analysis
    Table 68. Janssen Recent Developments
    Table 69. Roche Company Details
    Table 70. Roche Business Overview
    Table 71. Roche NGS Based Diagnostics Product and Services
    Table 72. Roche NGS Based Diagnostics Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 73. Roche NGS Based Diagnostics SWOT Analysis
    Table 74. Roche Recent Developments
    Table 75. Qiagen Company Details
    Table 76. Qiagen Business Overview
    Table 77. Qiagen NGS Based Diagnostics Product and Services
    Table 78. Qiagen NGS Based Diagnostics Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 79. Qiagen NGS Based Diagnostics SWOT Analysis
    Table 80. Qiagen Recent Developments
    Table 81. ThermoFisher Scientific Company Details
    Table 82. ThermoFisher Scientific Business Overview
    Table 83. ThermoFisher Scientific NGS Based Diagnostics Product and Services
    Table 84. ThermoFisher Scientific NGS Based Diagnostics Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 85. ThermoFisher Scientific NGS Based Diagnostics SWOT Analysis
    Table 86. ThermoFisher Scientific Recent Developments
    Table 87. Oxford Gene Technology Company Details
    Table 88. Oxford Gene Technology Business Overview
    Table 89. Oxford Gene Technology NGS Based Diagnostics Product and Services
    Table 90. Oxford Gene Technology NGS Based Diagnostics Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 91. Oxford Gene Technology NGS Based Diagnostics SWOT Analysis
    Table 92. Oxford Gene Technology Recent Developments
    Table 93. Illumina Company Details
    Table 94. Illumina Business Overview
    Table 95. Illumina NGS Based Diagnostics Product and Services
    Table 96. Illumina NGS Based Diagnostics Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 97. Illumina NGS Based Diagnostics SWOT Analysis
    Table 98. Illumina Recent Developments
    Table 99. Pacific Biosciences Company Details
    Table 100. Pacific Biosciences Business Overview
    Table 101. Pacific Biosciences NGS Based Diagnostics Product and Services
    Table 102. Pacific Biosciences NGS Based Diagnostics Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 103. Pacific Biosciences NGS Based Diagnostics SWOT Analysis
    Table 104. Pacific Biosciences Recent Developments
    Table 105. Paradigm Diagnostics Company Details
    Table 106. Paradigm Diagnostics Business Overview
    Table 107. Paradigm Diagnostics NGS Based Diagnostics Product and Services
    Table 108. Paradigm Diagnostics NGS Based Diagnostics Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 109. Paradigm Diagnostics NGS Based Diagnostics SWOT Analysis
    Table 110. Paradigm Diagnostics Recent Developments
    Table 111. Innogene Kalbiotech Company Details
    Table 112. Innogene Kalbiotech Business Overview
    Table 113. Innogene Kalbiotech NGS Based Diagnostics Product and Services
    Table 114. Innogene Kalbiotech NGS Based Diagnostics Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 115. Innogene Kalbiotech NGS Based Diagnostics SWOT Analysis
    Table 116. Innogene Kalbiotech Recent Developments
    Table 117. Admera Health Company Details
    Table 118. Admera Health Business Overview
    Table 119. Admera Health NGS Based Diagnostics Product and Services
    Table 120. Admera Health NGS Based Diagnostics Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 121. Admera Health NGS Based Diagnostics SWOT Analysis
    Table 122. Admera Health Recent Developments
    Table 123. AITbiotech Company Details
    Table 124. AITbiotech Business Overview
    Table 125. AITbiotech NGS Based Diagnostics Product and Services
    Table 126. AITbiotech NGS Based Diagnostics Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 127. AITbiotech Recent Developments
    Table 128. Centogene Company Details
    Table 129. Centogene Business Overview
    Table 130. Centogene NGS Based Diagnostics Product and Services
    Table 131. Centogene NGS Based Diagnostics Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 132. Centogene Recent Developments
    Table 133. Phalanx Biotech Group Company Details
    Table 134. Phalanx Biotech Group Business Overview
    Table 135. Phalanx Biotech Group NGS Based Diagnostics Product and Services
    Table 136. Phalanx Biotech Group NGS Based Diagnostics Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 137. Phalanx Biotech Group Recent Developments
    Table 138. iGenomX Company Details
    Table 139. iGenomX Business Overview
    Table 140. iGenomX NGS Based Diagnostics Product and Services
    Table 141. iGenomX NGS Based Diagnostics Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 142. iGenomX Recent Developments
    Table 143. NGS Based Diagnostics Market Trends
    Table 144. NGS Based Diagnostics Market Drivers
    Table 145. NGS Based Diagnostics Market Challenges
    Table 146. NGS Based Diagnostics Market Restraints
    Table 147. Research Programs/Design for This Report
    Table 148. Key Data Information from Secondary Sources
    Table 149. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global NGS Based Diagnostics Sales Market Share by Type: 2021 VS 2028
    Figure 2. DNA Sequencing Features
    Figure 3. RNA Sequencing Features
    Figure 4. Whole Genome Sequencing Features
    Figure 5. Whole Exome Sequencing Features
    Figure 6. Other Features
    Figure 7. Global NGS Based Diagnostics Sales Market Share by Application: 2021 VS 2028
    Figure 8. Hospitals Case Studies
    Figure 9. Clinics Case Studies
    Figure 10. Academics/Research Institutions Case Studies
    Figure 11. NGS Based Diagnostics Report Years Considered
    Figure 12. Global NGS Based Diagnostics Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global NGS Based Diagnostics Market Size 2017-2028 (US$ Million)
    Figure 14. Global NGS Based Diagnostics Market Size Market Share by Region: 2021 VS 2028
    Figure 15. Global NGS Based Diagnostics Revenue Market Share by Region in 2017 VS 2022
    Figure 16. Global Top 10 NGS Based Diagnostics Countries Ranking by Market Size (US$ Million) in 2021
    Figure 17. Global NGS Based Diagnostics Market Share by Players in 2021
    Figure 18. Global Top NGS Based Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS Based Diagnostics as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by NGS Based Diagnostics Revenue in 2021
    Figure 20. North America NGS Based Diagnostics Revenue Market Share by Company in 2021
    Figure 21. North America NGS Based Diagnostics Revenue Market Share by Type (2017-2028)
    Figure 22. North America NGS Based Diagnostics Revenue Market Share by Application (2017-2028)
    Figure 23. North America NGS Based Diagnostics Revenue Share by Country (2017-2028)
    Figure 24. U.S. NGS Based Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 25. Canada NGS Based Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 26. Europe NGS Based Diagnostics Revenue Market Share by Company in 2021
    Figure 27. Europe NGS Based Diagnostics Revenue Market Share by Type (2017-2028)
    Figure 28. Europe NGS Based Diagnostics Revenue Market Share by Application (2017-2028)
    Figure 29. Europe NGS Based Diagnostics Revenue Share by Country (2017-2028)
    Figure 30. Germany NGS Based Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 31. France NGS Based Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 32. U.K. NGS Based Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 33. Italy NGS Based Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 34. Russia NGS Based Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 35. Asia Pacific NGS Based Diagnostics Revenue Market Share by Company in 2021
    Figure 36. Asia Pacific NGS Based Diagnostics Revenue Market Share by Type (2017-2028)
    Figure 37. Asia Pacific NGS Based Diagnostics Revenue Market Share by Application (2017-2028)
    Figure 38. Asia Pacific NGS Based Diagnostics Revenue Share by Region (2017-2028)
    Figure 39. China NGS Based Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 40. Japan NGS Based Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 41. South Korea NGS Based Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 42. India NGS Based Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 43. Australia NGS Based Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 44. Taiwan NGS Based Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 45. Indonesia NGS Based Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 46. Thailand NGS Based Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 47. Malaysia NGS Based Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 48. Philippines NGS Based Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 49. Vietnam NGS Based Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 50. Latin America NGS Based Diagnostics Revenue Market Share by Company in 2021
    Figure 51. Latin America NGS Based Diagnostics Revenue Market Share by Type (2017-2028)
    Figure 52. Latin America NGS Based Diagnostics Revenue Market Share by Application (2017-2028)
    Figure 53. Latin America NGS Based Diagnostics Revenue Share by Country (2017-2028)
    Figure 54. Mexico NGS Based Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 55. Brazil NGS Based Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 56. Argentina NGS Based Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 57. Middle East and Africa NGS Based Diagnostics Revenue Market Share by Company in 2021
    Figure 58. Middle East and Africa NGS Based Diagnostics Revenue Market Share by Type (2017-2028)
    Figure 59. Middle East and Africa NGS Based Diagnostics Revenue Market Share by Application (2017-2028)
    Figure 60. Middle East and Africa NGS Based Diagnostics Revenue Share by Country (2017-2028)
    Figure 61. Turkey NGS Based Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 62. Saudi Arabia NGS Based Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 63. UAE NGS Based Diagnostics Revenue (2017-2028) & (US$ Million)
    Figure 64. Janssen Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 65. Roche Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 66. Qiagen Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 67. ThermoFisher Scientific Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 68. Oxford Gene Technology Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 69. Illumina Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 70. Pacific Biosciences Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 71. Paradigm Diagnostics Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 72. Innogene Kalbiotech Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 73. Admera Health Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 74. AITbiotech Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 75. Centogene Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 76. Phalanx Biotech Group Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 77. iGenomX Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed

Keyplayers in Global NGS Based Diagnostics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Janssen
Roche
Qiagen
ThermoFisher Scientific
Oxford Gene Technology
Illumina
Pacific Biosciences
Paradigm Diagnostics
Innogene Kalbiotech
Admera Health
AITbiotech
Centogene
Phalanx Biotech Group
iGenomX

REQUEST SUMMARY

Request Sample

Pre-order Enquiry

Request Discount

Contact Information

24/7 Research Support

Phone: +1 424 253 0807

[email protected]